Effect of Crack Patterns in Calcified Plaque on Lumen Area after Stenting for a Severe Calcified Coronary Artery (from the Optical Frequency Domain Imaging-Guided Percutaneous Coronary Artery Intervention for Calcified Lesion Registry)

Table 1

Baseline clinical characteristics.

Variable	n = 50
Age (years)	74.9 ± 7.9
Male	34 (68%)
BMI (kg/m^2)	23.4 ± 3.8
Hypertension	46 (92%)
Dyslipidemia	36 (72%)
Current smoker	9 (18%)
Diabetes mellitus	27 (54%)
Atrial fibrillation	4 (8%)
LVEF (%)	63.8 ± 12.2
ESRD on HD	3 (6%)
eGFR≤60 without HD (mL/min/1.73 m^2)	25 (50%)
PAD	6 (12%)
COPD	1 (2%)
Aortic disease	1 (2%)
Prior PCI	21 (42%)
Prior CABG	2 (4%)
Prior stroke	6 (12%)
CHF	7 (14%)
Prior MI	18 (36%)
SYNTAX score	21.5 ± 22.9
SYNTAX2 score (PCI)	34.3 ± 15.9
Acute coronary syndrome	5 (10%)
Multivessel disease	27 (54%)
Medications
Aspirin	49 (98%)
Thienopyridine	50 (100%)
OAC	5 (10%)
Statins	43 (86%)
β-blockers	25 (50%)
ACE-I/ARB	30 (60%)

Data are presented as number (%) or mean ± standard deviation, unless otherwise noted. ACE-I, angiotensin-converting-enzyme inhibitor; ARB, angiotensinI receptor blocker; BMI, body mass index; CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HD, hemodialysis; LVEF, left ventricular ejection fraction; MI, myocardial infarction; OAC, oral anticoagulants; PAD, peripheral artery disease; PCI, percutaneous coronary intervention.